As the global health financing narrative focuses on attracting, or leveraging, additional resources, there is renewed interest in innovative financing, a concept that also garnered attention during the Millennium Development Goals (MDGs) era. Product (RED) and Debt2Health are examples used by the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) to mobilise additional resources.

Innovative financing is a broad topic, comprised of many mechanisms that seek to mobilise funds and increase the efficiency and effectiveness of resources in a wide range of global development contexts, including reducing repeat criminal offences, tax revenue generation for infrastructure.

This paper commissioned by the Communities Delegation and Civil Society Sustainability Network (CSSN) aims to provide a briefing paper that focuses on how innovative financing applies to the global health development context, specifically in the fight against HIV, TB and malaria where there do not appear to be standard definitions of innovative financing, nor are there data or evaluation on their effectiveness in the health context.